Welcome to the Canadian National Multilingual News Group (CNMNG). This is a project made possible through funding by Canadian Heritage. CNMNG aims to gather news researched and written by a corps of Canadian-based journalists/writers from the country’s multilingual community groups. The overall goal is to inform, analyze and critique the issues of the day in a professional manner and to provide that to publishers and editors active in the ethnocultural-multilingual press and media whose experience provides them with a perspective that is sensitive to news relevant to their own language group.
TORONTO – The number of people covered with Covid-19 in hospitals and intensive care units across Ontario is still decreasing. Today the total was 1,038 patients, therefore a further decrease compared to the 1,056 on Sunday (data were not provided on Monday, Family Day holiday). The last time the province had reported fewer than 1,038 people at hospital with the virus was on December 30, 2021, when there were 965 hospitalized. →
TORONTO – The threat posed by Omicron is frightening. The new variant has created a climate of great concern in the international scientific community, although at the moment there is no unequivocal assessment of this new threat. On the one hand, in fact, we have numerous virologists who have highlighted how the first data coming from South Africa and Europe have highlighted a greater transmissibility of the coronavirus and, at the same time, the presence of generally milder symptoms for the infected compared to the Delta strain and the other variants that have characterized this pandemic. →
TORONTO – Canada and Ontario are still grappling with the AstraZeneca node. The vaccine, although still considered safe by both Health Canada and the National Advisory Committee on Immunization (Naci) has been suspended as a precaution in some provinces of our country. In Ontario, as explained this week by Chief Medical Officer David Williams, the provisional stop was decided for two reasons: on the one hand the necessary caution pending new data on adverse reactions, on the other hand the lack of new supplies due to the announced delays in deliveries. →
